VP Venture Partners

VP Venture Partners is a venture capital investment firm founded in 2020 and based in Zurich, Switzerland. The firm focuses on investing in healthcare companies, specifically within the life science, medical devices, diagnostics, digital health, and medtech sectors across Europe. By targeting innovative enterprises in these fields, VP Venture Partners aims to support the development of transformative healthcare solutions.

Annick Bay

Investment Manager

Past deals in Zurich

Hemotune

Series B in 2024
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Hemotune

Series B in 2022
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.